Frequency and clinical significance of bloodstream infections caused by C. albicans strains with reduced susceptibility to fluconazole

This publication has 34 references indexed in Scilit:

• Trends in Antifungal Susceptibility among Swedish Candida Species Bloodstream Isolates from 1994 to 1998: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A Reference Method
  Journal of Clinical Microbiology, 2001
• Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
  International Journal of Antimicrobial Agents, 2000
• Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
  The Journal of Infectious Diseases, 2000
• The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active Surveillance
  Clinical Infectious Diseases, 1999
• Myelofibrosis Complicated by Infection Due toCandida albicans: Emergence of Resistance to Antifungal Agents During Therapy
  Clinical Infectious Diseases, 1997
• Fluconazol‐resistente Candida‐Arten bei HIV‐Patienten mit rezidivierenden Candida‐Stomatitiden: Kreuzresistenz zu Itraconazol und Ketoconazol
  Mycoses, 1997
• Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature
  Clinical Infectious Diseases, 1996
• The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
  The American Journal of Medicine, 1996
• Fungemia Due to Fluconazole-Resistant Candida albicans in a Patient with AIDS
  Clinical Infectious Diseases, 1994
• Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
  The Journal of Infectious Diseases, 1993